Orchard Therapeutics PLC
Mukesh Asarpota has over three decades of work experience in various IT leadership roles. Mukesh has worked for companies like Orchard Therapeutics, Salesforce, Watts Water Technologies, NTT DATA/Keane Inc., and AIG ME/India. Mukesh'sexpertise includes business platforms, technology initiatives, digital transformation, enterprise applications, database administration, and systems architecture. Mukesh has a track record of driving process improvements, automation, and technology solutions to support business growth and scale goals.
Mukesh Asarpota holds a Masters in Computer Science from the University of Massachusetts Lowell, completed between 1986 and 1988. In 2013, they attended the MIT Sloan School of Management for an Executive Program focusing on CIO Leadership Institute. In 2020, Mukesh obtained a certification in Board Leadership from KPMG.
This person is not in any offices
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.